Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
6.20
↓ 96% below average
Average (9y)
161.23
Historical baseline
Range
High:1256.70
Low:6.20
CAGR
-44.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 6.20 | -21.9% |
| 2023 | 7.95 | -38.2% |
| 2022 | 12.86 | +42.0% |
| 2021 | 9.05 | -62.0% |
| 2020 | 23.85 | -3.4% |
| 2019 | 24.69 | +2.1% |
| 2018 | 24.18 | +20.4% |
| 2017 | 20.08 | -91.1% |
| 2016 | 226.73 | -82.0% |
| 2015 | 1256.70 | - |